Cohance Lifesciences share price
Cohance Lifesciences Ltd. · NSE: COHANCE · Healthcare
Price, one year
Price range
- Open
- ₹453.00
- High
- ₹454.00
- Low
- ₹437.40
- Previous close
- ₹453.85
- Volume
- 5.7 L
- Market cap
- ₹17,211 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- 161.8
- Price to book
- 4.4
- Return on equity
- 2.7%
- EPS (TTM)
- ₹2.78
- Book value / share
- ₹102.23
- Debt to equity
- 0.04
- Revenue (TTM)
- ₹2,142 Cr
- Net profit (TTM)
- ₹106 Cr
- Sales growth, YoY
- −23.1%
- Profit growth, YoY
- −149.3%
- Operating margin
- 14.8%
- Net margin
- 5.0%
- Sales CAGR, 3 years
- +19.2%
- Profit CAGR, 3 years
- −24.2%
- Promoter holding
- 57.48%
- Promoter shares pledged
- 94.56%
Shareholding pattern
% of shares| Holder | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 57.49 | 57.49 | 57.48 |
| Foreign institutions | 5.59 | 6.50 | 7.71 |
| Domestic institutions | 21.79 | 20.09 | 18.86 |
| Mutual funds | 18.57 | 18.21 | 16.93 |
| Retail and others | 7.03 | 7.71 | 7.49 |
| Promoter pledge | 0.00 | 94.56 | 94.56 |
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 5 Aug 2026.
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,748.00 | −0.57% |
| Divi's LaboratoriesDIVISLAB | ₹8,950.00 | −2.31% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,524.40 | −1.97% |
| Zydus LifesciencesZYDUSLIFE | ₹1,129.40 | −0.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,730.00 | +1.65% |
| CiplaCIPLA | ₹1,338.00 | +0.53% |
| Laurus LabsLAURUSLABS | ₹1,970.00 | −1.62% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,229.50 | −0.77% |
| Mankind PharmaMANKIND | ₹2,212.60 | −2.77% |
| Aurobindo PharmaAUROPHARMA | ₹1,571.70 | −2.43% |
Frequently asked questions
What is the share price of Cohance Lifesciences today?
Cohance Lifesciences (NSE: COHANCE) was at ₹449.85 on 23 Oct 2026, a change of −0.88% from the previous close.
What are the 52-week high and low of Cohance Lifesciences?
Over the last 52 weeks Cohance Lifesciences traded between ₹266.70 and ₹917.85 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Cohance Lifesciences?
About ₹17,211 Cr at the latest price, with a P/E of 161.8, a price-to-book of 4.4, a return on equity of 2.7%. Ratios use the company's latest reported results.
Who owns Cohance Lifesciences shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 57.48%, foreign institutions 7.71%, domestic institutions 18.86%.
Which sector and indices does Cohance Lifesciences belong to?
NSE classifies Cohance Lifesciences under Healthcare; it is a member of Nifty 500.
Follow Cohance Lifesciences with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Start free trial